David Shaw’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

David Shaw’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$953K	–	4173
2019 Q2	$953K	Hold	10,000	–	–	﹤0.01%	2697
2019 Q1	$913K	Buy	+10,000	New	+$818K	﹤0.01%	2657
2016 Q4	–	Sell	-10,000	Closed	-$1.25M	–	3725
2016 Q3	$1.25M	Sell	10,000 -10,900	-52%	-$1.29M	﹤0.01%	2256
2016 Q2	$2.22M	Buy	20,900 +10,000	+92%	+$1.16M	﹤0.01%	1861
2016 Q1	$1.25M	Sell	10,900 -4,500	-29%	-$528K	﹤0.01%	2212
2015 Q4	$2.19M	Buy	15,400 +900	+6%	+$104K	﹤0.01%	2059
2015 Q3	$1.3M	Buy	14,500 +4,500	+45%	+$475K	﹤0.01%	2416
2015 Q2	$1.15M	Buy	+10,000	New	+$1.05M	﹤0.01%	2593

David Shaw's CBPO Position: Q2 2021 in Review

David Shaw sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 21,714 shares — an estimated $2.57M sold.

David Shaw first reported a position in CBPO in Q2 2014 and held it in 28 quarters. The position peaked at $17.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

David Shaw reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
David Shaw sold 21,714 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.57M.
David Shaw first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 28 quarters.
David Shaw's China Biologic Products Holdings, Inc. position peaked at $17.8M in Q2 2018.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.